A new agreement between Enterprise Ireland and Parkview Health could give Irish healthcare innovators a clearer route into the United States, combining clinical expertise, market knowledge and opportunities to test emerging technologies in a real healthcare setting.
The strategic alliance was formalised through a Memorandum of Understanding signed in Dublin on 25 September 2026. It is designed to support Irish companies developing solutions for hospitals, clinicians and patients, particularly as demand grows for practical digital and data-led healthcare tools.
A bridge between Irish innovation and US healthcare delivery
Enterprise Ireland, the government agency responsible for helping Irish companies grow in international markets, will work with Parkview Health to identify opportunities for collaboration. The partnership is intended to help client companies validate products, understand healthcare operations and progress towards commercial adoption in the US.
For companies entering the American market, access to a major health system can provide insight that is difficult to obtain through market research alone. Clinical feedback, operational testing and engagement with healthcare professionals may help innovators refine their products before wider rollout.
The agreement will focus on several areas:
- Digital health and telehealth services
- Medical technologies and therapeutics
- Hospital operations and workflow tools
- Clinical research
- Artificial intelligence-enabled healthcare solutions
Why the alliance matters for Irish companies
The United States remains the world’s largest healthcare market and an important destination for Irish life sciences and health technology businesses seeking international growth. However, entering the market can involve complex procurement processes, regulatory requirements and differing models of care.
Parkview Health’s clinical and administrative expertise may help participating companies better understand those challenges. The Indiana-based nonprofit health system operates 16 hospitals and a broad network of primary and specialist physicians across Indiana and northwest Ohio. It is also the largest employer in northeast Indiana, with nearly 20,000 co-workers.
Enterprise Ireland said the partnership will strengthen its network of US healthcare partners and create additional pathways for companies to engage with providers, validate technologies and accelerate international expansion.
Part of Ireland’s wider health technology growth
The alliance comes as Ireland continues to build on its established strengths in medtech, biopharmaceuticals, research and commercialisation. Enterprise Ireland highlighted the country’s connected innovation ecosystem, which supports companies from early-stage development through regulatory approval and global scaling.
In 2024, PitchBook named Enterprise Ireland the world’s most active life sciences and health tech venture capital investor by deal count, with participation in 60 deals. The agency also reported €491 million in life sciences and health tech investment in Ireland during that year.
For emerging companies, partnerships with health systems can be especially valuable. They can offer a path to practical testing, help identify unmet needs and create stronger evidence for future customers, investors and commercial partners.
Read more
Explore related coverage on Irish startups, enterprise growth and innovation across Ireland, including developments affecting founders and scaling businesses.
Explore more
For further perspectives on Ireland’s technology and business landscape and innovation-led industries and investment trends, visit our partner publications.
What happens next?
The agreement establishes a framework rather than announcing a specific product launch or investment. Its impact will depend on how companies and Parkview teams turn the relationship into pilot projects, clinical collaborations and commercial opportunities.
For Irish healthcare businesses, the message is clear: international scale is increasingly linked to strong local partnerships in target markets. By connecting innovation with frontline healthcare expertise, this alliance could help promising solutions move more efficiently from development to adoption.
Frequently asked questions
What is the new Enterprise Ireland agreement?
It is a strategic alliance with Parkview Health, formalised through a Memorandum of Understanding, to support healthcare innovation and commercial opportunities for Irish companies in the US.
Which technologies are covered?
The collaboration includes digital health, telehealth, medtech, therapeutics, clinical research, hospital operations and AI-enabled healthcare solutions.
How could Irish companies benefit?
Eligible Enterprise Ireland client companies may gain access to clinical and administrative expertise that can support product validation, market understanding and international scaling.
Key takeaway: The Enterprise Ireland–Parkview Health alliance strengthens the bridge between Ireland’s healthcare innovation ecosystem and the US market, giving Irish companies potential access to valuable clinical insight and commercial pathways.
